PRINCETON, N.J.--(BUSINESS WIRE)--Derma Sciences, Inc. (OTCBB: DSCI), a manufacturer and full line supplier of advanced wound care products, today announced that it has obtained FDA clearance to market and sell its MOBILITY-1™ boot and compressor device for the treatment of Chronic Venous Insufficiency (CVI), Deep Vein Thrombosis (DVT) prevention, venous ulcers, lymphedema, and other conditions that require compression therapy, including the enhancement of blood circulation during recovery from coronary artery bypass graft surgery and orthopedic hip and knee replacements.
